Santi Nolasco

Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use.

R. Intravaia, R. Campisi, C. Crimi, 2020, F1000Research.

Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use

R. Intravaia, R. Campisi, C. Crimi, 2020, F1000Research.

High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial

F. Madotto, C. Gregoretti, R. Scala, 2022, Thorax.

Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program

B. Beghé, N. Scichilone, A. Papi, 2021, Journal of asthma and allergy.

Benralizumab effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicentre Study.

M. D’Amato, G. E. Carpagnano, N. Scichilone, 2021, The journal of allergy and clinical immunology. In practice.

Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

M. D’Amato, G. E. Carpagnano, N. Scichilone, 2021, Journal of asthma and allergy.

Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report.

R. Campisi, C. Crimi, Santi Nolasco, 2022, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children

C. Vancheri, S. Manti, S. Leonardi, 2022, Frontiers in Medicine.

Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use [version 2; peer review: 2 approved]

R. Intravaia, R. Campisi, C. Crimi, 2022 .

Practical considerations for spirometry during the COVID-19 outbreak: Literature review and insights

A. Spanevello, R. Campisi, C. Crimi, 2020, Pulmonology.